• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Indonesia·Healthcare·OMED.JK
Share

PT Jayamas Medica Industri Tbk Stocks

IDR 166Last Updated 09.11.2026

Issuer Rating

4/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

IDR 262.52M

IDR 166
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Operating under its OneMed brand, PT Jayamas Medica Industri Tbk specializes in the production and distribution of a diverse array of medical devices and supplies. The company's reach extends across Indonesia, Asia, the United States, South America, and Africa. Its business operations are structured into three primary segments: manufacturing, distribution, and retail. The extensive product portfolio includes a comprehensive selection of disposable and consumable medical items, such as syringes, gauze, plaster bandages, masks, medical gloves, urine bags, foley catheters, and alcoholic tissues. Additionally, it provides various antiseptic and disinfectant solutions, including povidone iodine, medical alcohol, and blood cleansing liquids like Hdsol. Diagnostic instruments and equipment form another key category, offering everything from patient monitors, vital signs monitors, and ECG readers to syringe pumps, infusion pumps, tensimeters, and oxymeters. For mobility and rehabilitation, the company supplies products like wheelchairs, crutches, and walkers. Its biotechnology and laboratory offerings encompass pregnancy tests, PCR tests, blood collection tubes, PCT tubes, and chemical reagents. Rounding out its inventory are hospital furnishings, such as patient beds, bedside cabinets, pediatric patient beds, and surgical lamps, alongside other general consumer medical products. These essential medical goods are distributed and retailed through the company's network of Medicom stores and various digital platforms. PT Jayamas Medica Industri Tbk was founded in Sidoarjo, Indonesia, in 2000 and functions as a subsidiary of Pt. Intisumber Hasilsempurna.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, trad

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Very favourable
7/7

The average target price of OMED.JK is 281 and suggests 69% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

11.11.2026 05:26

Nebius's Nvidia-backed competitor may postpone its IPO — The Telegraph

11.11.2026 02:45

CoreWeave exceeded Wall Street's expectations. Will this ease concerns about neo-clouds?

11.11.2026 02:17

Stocks fell, and bonds experienced one of their biggest sell-offs: the market is waiting for the Fed to act

11.11.2026 01:51

Money managers seek shelter from AI risks in emerging markets. What are they buying?

11.11.2026 00:09

Boeing books most October aircraft orders in almost three decades

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026